LON:LLAI LungLife AI (LLAI) Share Price, News & Analysis → The Military's $700M 'AI Software Bullet' (From Behind the Markets) (Ad) Free LLAI Stock Alerts GBX 17 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range 16▼ 1750-Day Range 16▼ 3352-Week Range 16▼ 142.10Volume3,730 shsAverage Volume25,731 shsMarket Capitalization£5.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get LungLife AI alerts: Email Address Ad Behind the MarketsProtect Your Bank Account from ChinaChina is set to launch a gold-backed currency that could shake the financial world. This move will give them unprecedented power over global finance. And could divert trillions from U.S. Treasury bonds.Discover these 4 simple steps here >>> About LungLife AILungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. It engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.Read More LLAI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LLAI Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive LLAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LungLife AI and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:LLAI CUSIPN/A CIKN/A Weblunglifeai.com Phone805 409 9868FaxN/AEmployees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-5,410,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-51.42% Return on Assets-28.69% Debt Debt-to-Equity Ratio4.37 Current Ratio2.28 Quick Ratio9.85 Sales & Book Value Annual Sales£98,566.00 Price / Sales52.88 Cash FlowGBX 7.46 per share Price / Cash Flow2.28 Book ValueGBX 31 per share Price / Book0.55Miscellaneous Outstanding Shares30,660,000Free FloatN/AMarket Cap£5.21 million OptionableNot Optionable Beta-0.19 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Paul Pagano Ph.D. (Age 39)CEO, Chief Scientific Officer & Executive Director Comp: $248.9kMr. David M. Anderson (Age 61)CFO, Company Secretary & Executive Director Comp: $187.74kKey CompetitorsVerici DxLON:VRCIYourgene HealthLON:YGENAbingdon HealthLON:ABDXGENinCodeLON:GENIProteome SciencesLON:PRMView All CompetitorsInsidersPaul Carmelo PaganoBought 12,123 shares on 8/14/2023Total: £848,610.00 ($70.00/share) LLAI Stock Analysis - Frequently Asked Questions How have LLAI shares performed in 2024? LungLife AI's stock was trading at GBX 46 at the start of the year. Since then, LLAI shares have decreased by 63.0% and is now trading at GBX 17. View the best growth stocks for 2024 here. How do I buy shares of LungLife AI? Shares of LLAI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:LLAI) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LungLife AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LungLife AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.